Cannabis Law Report

JUNE 21, 2021

We conclude that in medical-only access models there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications with potentially impairing effects. Behaviours and Health Risks Program, Burnet Institute, Melbourne, VIC 3004, Australia. Road safety.

Medicine 59

Medicine Safety Policy Treatment 59

Cannabis Law Report

JUNE 12, 2021

Road safety risks associated with medicinal cannabis appear similar or lower than numerous other potentially impairing prescription medications. The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney, NSW 2050, Australia. methadone) demonstrate a feasible alternative approach.

Policy 66

Policy Safety Medicine Access 66

NORML

FEBRUARY 23, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. The bill would allow qualifying patients to access all the alternative treatment centers instead of having to designate just one.

Legislation 239

Legislation Patients Decriminalization Access 239